← Back
$EYPT All transactions

EyePoint Pharmaceuticals, Inc.

G

$ Value

$0

Shares

20,000

Price

$0

Filed

Sep 22

Insider

Name

Elston George

Title

Chief Financial Officer

CIK

0001429932

Roles

Officer

Transaction Details

Transaction Date

2025-09-19

Code

G

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

62,114

Footnotes

On September 19, 2025, the reporting person transferred owned shares of Common Stock of the Company to an irrevocable family trust of which JP Morgan Trust Company of Delaware is trustee and of which the reporting person's immediate family members are the sole beneficiaries (the "Family Trust"). | Includes 1,266 shares acquired on July 31, 2025, pursuant to EyePoint's 2019 Employee Stock Purchase Plan. | These securities are held in a trust for the benefit of the reporting person's children. JP Morgan Trust Company of Delaware is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Filing Info

Accession No.

0001429932-25-000005

Form Type

4

Issuer CIK

0001314102

Elston George's History

Date Ticker Type Value
2026-01-06 EYPT M $0
2026-01-06 EYPT F $76K
2026-01-06 EYPT M $0
2026-01-05 EYPT M $0
2026-01-05 EYPT F $77K
2026-01-05 EYPT M $0
2026-01-03 EYPT M $0
2026-01-03 EYPT F $111K
2026-01-03 EYPT M $0
2026-01-02 EYPT A $0

Other Insiders at EYPT (90d)

Insider Bought Sold Last
Duker Jay S.
President and CEO
2026-03-23
Ribeiro Ramiro
Chief Medical Officer
$73K 2026-04-17